Stopping aspirin after heart pump implant surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether patients with an artificial heart pump (CH-VAD) can safely stop taking aspirin after surgery. Aspirin is often given to prevent blood clots, but this trial wants to see if it's really necessary for this specific pump.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have had a CH-VAD pump implanted as your first (and only) artificial heart pump
- You can take medications by mouth starting within 7 days after surgery
- You do not have an allergy to aspirin
- You do not need additional heart pumps or mechanical support after implantation
- Your doctor has not ordered you to stay on aspirin for other medical reasons
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.
This trial tests if the blood thinner apixaban (Eliquis) is as safe and effective as warfarin (Coumadin) for people with a HeartMate 3 LVAD heart pump. The goal is to find a simpler, more stable option for preventing blood clots.
This trial studies a “double anti-platelet” medicine plan (aspirin plus clopidogrel) after closing the left atrial appendage, a procedure used to reduce stroke risk in some heart rhythm conditions. It aims to find a safer, better medicine strategy for people who cannot take standard blood thinners.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This trial compares aspirin to warfarin in the first six months after receiving a bioprosthetic (tissue) heart valve. It aims to find which treatment better prevents blood clots without causing excessive bleeding.
This study tests if a slightly lower dose of the blood thinner warfarin can lower the risk of stomach or other bleeding, while still protecting against blood clots, in people who have a HeartMate 3 heart pump.
Hear when a new LVAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.